Multiple Sclerosis Discovery Forum

Inspiring Connections

Most Viewed Papers

Primary progressive multiple sclerosis developing in the context of young onset Parkinson's disease.
Re: S Shahrbanian, M Auais, P Duquette, K Anderson, NE Mayo. Does pain in individuals with multiple sclerosis affect employment? A systematic review and meta-analysis. Pain Res Manag 2013;18(5):e94-e100.
Novel p75 neurotrophin receptor ligand stabilizes neuronal calcium, preserves mitochondrial movement and protects against HIV associated neuropathogenesis.
Patterns Of Use Of Tests To Monitor Disease Activity Among Patients Currently Treated For Relapsing Remitting Multiple Sclerosis (Rrms) In Europe.
Determinants of Psychosocial Difficulties Experienced by Persons with Brain Disorders: Towards a 'Horizontal Epidemiology' Approach.
Multiple sclerosis: Smoking in patients with multiple sclerosis-is it ever too late to quit?
Behcet's disease.
Increased Concentrations of Interleukin-33 in the Serum and Cerebrospinal Fluid of Patients with Multiple Sclerosis.
Microglial priming through the lung-brain axis: the role of air pollution-induced circulating factors.
Perioperative management of a patient undergoing a novel mini-invasive percutaneous transcatheter left ventricular reconstruction procedure.
Increased expression ratio of matrix metalloproteinase-9 (MMP9) and tissue inhibitor of matrix metalloproteinase (TIMP-1) RNA levels in Iranian multiple sclerosis patients.
The relationship between the rate of brain volume loss during first 24 months and disability progression over 24 and 48 months in relapsing MS.
[Molecular genetic characteristics of the virus isolated from patients with human acute encephalomyelitis and multiple sclerosis].
How Fatigue Influences Exercise Participation in Men With Multiple Sclerosis.
Childhood-onset multiple sclerosis: report of 82 patients from Isfahan, Iran.
Fatal herpes encephalitis in a patient with small cell lung cancer following prophylactic cranial radiation - a case report with review of literature.
Autoantibodies to tetraspanins (CD9, CD81 and CD82) in demyelinating diseases.
Cytoskeletal Linker Protein Dystonin Is Not Critical to Terminal Oligodendrocyte Differentiation or CNS Myelination.
Development of Ms Budget Manager: A Practical Tool to Assist Alternative Stakeholders At Multiple Decision Levels In The Forecast And Financial Management For Multiple Sclerosis (Ms).
Demonstration of equivalence of a generic glatiramer acetate (Glatopa™).
Dual destructive and protective roles of adaptive immunity in neurodegenerative disorders.
Positive association of vitamin d receptor gene variations with multiple sclerosis in South East Iranian population.
Demyelinating and thrombotic diseases of the central nervous system: common pathogenic and triggering factors.
Survey of Neurologist's Current Practices in Evaluation of Multiple Sclerosis to Identify Domains for a New Clinician-Reported Measure.
Comparison of Patients With Relapsing Remitting Multiple Sclerosis (Rrms) Treated With Disease Modifying Treatments (Dmt) In Europe (Eu) And The United States (Us).

Pages